Fundraising September 15, 2024 – October 1, 2024 About fundraising

HIV/HCV therapy with ledipasvir/sofosbuvir after randomized...

PLoS ONE 2020 / 1 Vol. 15; Iss. 1

HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens

Huhn, Gregory D., Ramgopal, Moti, Jain, Mamta K., Hinestrosa, Federico, Asmuth, David M., Slim, Jihad, Goldstein, Deborah, Applin, Shauna, Ryu, Julie H., Jiang, Shuping, Cox, Stephanie, Das, Moupali,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
15
Language:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0224875
Date:
January, 2020
File:
PDF, 716 KB
english, 2020
Conversion to is in progress
Conversion to is failed